Evidence map›Paper›PMID 27810900›Full record

ArticleThe Journal of biological chemistry2016

Endoplasmic Reticulum Stress-induced Hepatocellular Death Pathways Mediate Liver Injury and Fibrosis via Stimulator of Interferon Genes.

Arvin Iracheta-Vellve, Jan Petrasek, Benedek Gyongyosi, Abhishek Satishchandran, Patrick Lowe, Karen Kodys, Donna Catalano, Charles D Calenda, Evelyn A Kurt-Jones, Katherine A Fitzgerald and 1 more

Open access · hybridAbstract read
In one paragraph

Article in The Journal of biological chemistry, 2016. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 98 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
98citing papers in PubMed, 1 pooled it
5.9field-weighted citation impact, top 3% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

98 citing papers in PubMed, 1 synthesis or guideline pooled it, 148 citations in OpenAlex.

  1. Pooled it
  2. Article
  3. Review
  4. Article
  5. Article
  6. Review
  7. Review
  8. Review
  9. Review
  10. Review
  11. Article
  12. Review
  13. Article
  14. The Role of Interferon Regulatory Factors in Liver Diseases.International journal of molecular sciences · 2024
    Review
  15. Review
  16. Article
  17. Article
  18. Review
  19. Article
  20. Review

38 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

11 authors at 1 institution in 1 country.

Arvin Iracheta-VellveFrom the Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Jan PetrasekFrom the Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Benedek GyongyosiFrom the Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Abhishek SatishchandranFrom the Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Patrick LoweFrom the Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Karen KodysFrom the Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Donna CatalanoFrom the Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Charles D CalendaFrom the Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Evelyn A Kurt-JonesFrom the Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Katherine A FitzgeraldFrom the Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605.
Gyongyi SzaboFrom the Department of Medicine, University of Massachusetts Medical School, Worcester, Massachusetts 01605 gyongyi.szabo@umassmed.edu.
University of Massachusetts Chan Medical School · US

Funding

MicroRNAs in Alcoholic Liver Disease Administrative SupplementR01AA020744 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SZABO, GYONGYI · 2011 to 2023
$5.3M
TLR4 Signaling in alcoholic liver diseaseR01AA017729 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI SZABO, GYONGYI · 2009 to 2021
$4.3M
STING and IRF3 activation by cyclic dinucleotides in early alcoholic liver diseaseF31AA025545 · NIAAA · UNIV OF MASSACHUSETTS MED SCH WORCESTER · PI IRACHETA-VELLVE, ARVIN · 2016 to 2017
$39k
NIAAA NIH HHS F31 AA025545NIAAA NIH HHS R01 AA017729NIAAA NIH HHS R01 AA020744
6 · The paper itself

Abstract

Fibrosis, driven by inflammation, marks the transition from benign to progressive stages of chronic liver diseases. Although inflammation promotes fibrogenesis, it is not known whether other events, such as hepatocyte death, are required for the development of fibrosis. Interferon regulatory factor 3 (IRF3) regulates hepatocyte apoptosis and production of type I IFNs. In the liver, IRF3 is activated via Toll-like receptor 4 (TLR4) signaling or the endoplasmic reticulum (ER) adapter, stimulator of interferon genes (STING). We hypothesized that IRF3-mediated hepatocyte death is an independent determinant of chemically induced liver fibrogenesis. To test this, we performed acute or chronic CCl

Indexed as

Endoplasmic Reticulum StressAnimalsCarbon TetrachlorideCells, CulturedChemical and Drug Induced Liver InjuryFemaleHepatocytesInterferon Regulatory Factor-3Liver CirrhosisMembrane ProteinsMiceMice, Inbred C57BLMice, KnockoutReceptor, Interferon alpha-betaSTING ProteinToll-Like Receptor 4Carbon TetrachlorideIfnar1 protein, mouseInterferon Regulatory Factor-3Irf3 protein, mouseMembrane ProteinsReceptor, Interferon alpha-betaSting1 protein, mouseSTING ProteinToll-Like Receptor 4apoptosisendoplasmic reticulum stress (ER stress)fibrosisinterferon regulatory factor (IRF)liver injury

Identifiers

PMID27810900
PMCPMC5207187
OpenAlexW2547204916

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.